NCT00110695
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- NSABP Operations Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Breast Diseases
Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.
10,357 public trials
1,987 recruiting studies
Breast Diseases trial results
NCT00314977
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
- Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands
- Rijnstate Ziekenhuis Arnhem, Netherlands
- Deventer Ziekenhuis Deventer, Netherlands
Completed
Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
NCT00191269
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
NCT00334802
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Ehime, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukuoka, Japan
Completed
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation Course
NCT01086683
- Conditions
- Breast Diseases, Breast Neoplasms, Colonic Diseases, +20 more
- Locations
-
- Department of Psychosocial Cancer Research Copenhagen, Denmark
NCT00191854
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santo André, Brazil
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. São Paulo, Brazil
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Beijing, China
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hangzhou, China
NCT00186680
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Stanford University School of Medicine Stanford, California, United States
NCT00261313
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
Not specified
NCT00124111
- Conditions
- Agranulocytosis, Breast Cancer, Breast Diseases, +11 more
- Locations
-
Not specified
NCT00038103
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Pfizer Investigational Site Dallas, Texas, United States
- Pfizer Investigational Site Antwerp, Belgium
- Pfizer Investigational Site Brussels, Belgium
- Pfizer Investigational Site Leuven, Belgium